Intensity Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of cancer drugs to treat solid tumors. Its lead product candidate includes INT230-6, a clinical trial for the treatment of refractory solid tumors and pancreatic, colon, bile duct, squamous cell carcinoma, sarcoma, breast, and liver cancers. The company was incorporated in 2012 and is headquartered in Westport, Connecticut.
What is the ticker symbol for Intensity Therapeutics, Inc? What does INTS stand for in stocks?
INTS is the stock ticker symbol of Intensity Therapeutics, Inc. Every public company that trades on a stock exchange gets a ticker symbol.
What is the market capital of Intensity Therapeutics, Inc (INTS)?
As of Fri Dec 20 2024, market cap of Intensity Therapeutics, Inc is 26.07 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.
What is the fair value of INTS stock?
You can check INTS's fair value in chart for subscribers.
Is Intensity Therapeutics, Inc a good stock to buy?
The fair value guage provides a quick view whether INTS is over valued or under valued. Whether Intensity Therapeutics, Inc is cheap or expensive depends on the assumptions which impact Intensity Therapeutics, Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for INTS.